According to a new brief by the Commonwealth Fund, an estimated 18.7 million U.S. women ages 19 to 64 were uninsured in 2010, up from 12.8 million in 2000. An additional 16.7 million women had health insurance but had such high out-of-pocket costs relative to their income that they were effectively underinsured in 2010.
In a communications bulletin released April 10, the U.S. Food and Drug Administration said it has completed its review of recent studies that looked at the risk of blood clots in women taking drospirenone-containing birth control pills.
Drospirenone is a synthetic version of the female hormone, progesterone, also referred to as a progestin. Based on this review, FDA has concluded that drospirenone-containing birth control pills may be associated with a higher risk for blood clots than other progestin-containing pills.
Approved oral contraceptives containing drospirenone include Beyaz, Loryna, Ocella, Safyral, Syeda, Yasmin, Yaz and Zarah.
The following chart shows the risk of developing a blood clot for women who are not pregnant and do not use birth control pills; for women who use birth control pills; for pregnant women; and for women in the postpartum period.
Once recommended every year, new screening guidelines from the U.S. Preventive Health Services Task Force now suggest women get fewer Pap smears to test for cervical cancer. Healthy women in their 20s should be screened every three years, and women 30 and older can either continue to be tested every three years with the Pap smear or test every five years with the Pap and a test for human papillomavirus, or HPV, the sexually transmitted infection that causes cervical cancer.
From lifting weights to getting enough sleep to eating certain foods, Women’s Health gives some easy-to-follow tips on how to help prevent diabetes.